Medicure Inc. (CVE:MPH – Get Free Report)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.79 and traded as high as C$0.89. Medicure shares last traded at C$0.89, with a volume of 6,996 shares.
Medicure Stock Performance
The firm has a market capitalization of C$9.29 million, a PE ratio of -4.57 and a beta of 0.90. The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29. The company’s fifty day simple moving average is C$0.79 and its 200 day simple moving average is C$0.89.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- What is the Dow Jones Industrial Average (DJIA)?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Profit From Value Investing
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Buy Cheap Stocks Step by Step
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
